Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis-Reference-Cited by-同舟云学术

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Published:2010-07 Issue:7 Volume:9 Page:740-750
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Polman Chris H,Bertolotto Antonio,Deisenhammer Florian,Giovannoni Gavin,Hartung Hans-Peter,Hemmer Bernhard,Killestein Joep,McFarland Henry F,Oger Joel,Pachner Andrew R,Petkau John,Reder Anthony T,Reingold Stephen C,Schellekens Huub,Sørensen Per Soelberg

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference76 articles.

1. Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomes;Deisenhammer;CNS Drugs,2009

2. Measuring and management of anti-interferon beta antibodies in subjects with multiple sclerosis;Farrell;Mult Scler,2007

3. Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology;Goodin;Neurology,2007

4. Neutralizing antibodies reduce the efficacy of βIFN during treatment of multiple sclerosis;Malucchi;Neurology,2004

5. Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group;Ross;Ann Neurol,2000

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple sclerosis;The Rose and Mackay Textbook of Autoimmune Diseases;2024

2. Global DNA Methylation and Hydroxymethylation Levels in PBMCs Are Altered in RRMS Patients Treated with IFN-β and GA—A Preliminary Study;International Journal of Molecular Sciences;2023-05-22

3. A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases;eBioMedicine;2023-03

4. Antibodies as tools in cytokine discovery and usage for diagnosis and therapy of inflammatory diseases;European Cytokine Network;2023-03

5. Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation;Brain Communications;2023-02-22